RFC
KYNB

Russell Frank Company’s Kyntra Bio KYNB Stock Holding History

Russell Frank Company’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$472K Hold
887
– – ﹤0.01% 2471
2015
Q4 		$689K Sell
887
-738
-45% -$490K ﹤0.01% 2372
2015
Q3 		$891K Buy
1,625
+1,171
+258% +$709K ﹤0.01% 2240
2015
Q2 		$267K Buy
+454
New +$264K ﹤0.01% 2744

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Russell Frank Company's KYNB Position: Q1 2016 in Review

Russell Frank Company held its Kyntra Bio (KYNB) position steady in Q1 2016 at 887 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #2471.

Russell Frank Company first reported a position in KYNB in Q2 2015 and has held it in 4 quarters since. The position peaked at $891K in Q3 2015. 134 funds tracked by Wall St. Rank hold KYNB as of Q1 2016.

  • Russell Frank Company held 887 shares of Kyntra Bio worth $472K as of Q1 2016.
  • Russell Frank Company left its Kyntra Bio share count unchanged in Q1 2016.
  • Kyntra Bio made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2471 holding.
  • Russell Frank Company first reported a position in Kyntra Bio in Q2 2015 and has held it in 4 quarters since.
  • Russell Frank Company's Kyntra Bio position peaked at $891K in Q3 2015.
  • 134 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.